IN2012DN04917A - - Google Patents

Download PDF

Info

Publication number
IN2012DN04917A
IN2012DN04917A IN4917DEN2012A IN2012DN04917A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A IN 4917DEN2012 A IN4917DEN2012 A IN 4917DEN2012A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A
Authority
IN
India
Prior art keywords
compounds
imidazo
methods
disclosed
pyridine
Prior art date
Application number
Other languages
English (en)
Inventor
Marvin J Miller
Garrett C Moraski
Lowell D Markley
George E Davis
Original Assignee
Univ Notre Dame Du Lac
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Notre Dame Du Lac, Dow Agrosciences Llc filed Critical Univ Notre Dame Du Lac
Publication of IN2012DN04917A publication Critical patent/IN2012DN04917A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN4917DEN2012 2009-11-05 2010-11-05 IN2012DN04917A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25854909P 2009-11-05 2009-11-05
PCT/US2010/055728 WO2011057145A2 (fr) 2009-11-05 2010-11-05 Composés d'imidazo[1,2-a]pyridine, leur synthèse et procédés pour les utiliser

Publications (1)

Publication Number Publication Date
IN2012DN04917A true IN2012DN04917A (fr) 2015-09-25

Family

ID=43970798

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4917DEN2012 IN2012DN04917A (fr) 2009-11-05 2010-11-05

Country Status (10)

Country Link
US (3) US9309238B2 (fr)
EP (2) EP2496578A4 (fr)
CN (3) CN102762556B (fr)
BR (1) BR112012010752B1 (fr)
HK (1) HK1248676A1 (fr)
IL (1) IL219564A (fr)
IN (1) IN2012DN04917A (fr)
RU (1) RU2608611C2 (fr)
WO (1) WO2011057145A2 (fr)
ZA (1) ZA201204028B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2496578A4 (fr) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac Composés d'imidazo[1,2-a]pyridine, leur synthèse et procédés pour les utiliser
CA2793086C (fr) * 2010-03-18 2018-08-21 Institut Pasteur Korea Composes d'imidazo[1,2-a]pyridine substitue et leur utilisation pour le traitement d'infections bacteriennes
TW201242965A (en) 2011-02-01 2012-11-01 Kyowa Hakko Kirin Co Ltd Ring-fused heterocyclic derivative
KR102104125B1 (ko) * 2011-04-21 2020-05-29 재단법인 한국파스퇴르연구소 소염 화합물
CA2852615A1 (fr) 2011-10-21 2013-04-25 Torrent Pharmaceuticals Limited Nouveaux imidazopiridines substitues comme modulateurs recepteurs gpbar1
EP2881394B1 (fr) 2012-07-31 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Composé hétérocyclique à cycles condensés
DK3027615T3 (da) * 2013-08-02 2021-10-25 Pasteur Institut Korea Antiinfektionsforbindelser
WO2015143652A1 (fr) * 2014-03-26 2015-10-01 Merck Sharp & Dohme Corp. Inhibiteurs de la kinase trka, compositions et méthodes associées
CN103965193B (zh) * 2014-05-30 2016-04-06 浙江司太立制药股份有限公司 N-(苯氧烷基)咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法
CN104628721A (zh) * 2015-01-22 2015-05-20 湖南华腾制药有限公司 一种咪唑并[1,2-a]吡啶衍生物的制备方法
BR112017028318B1 (pt) 2015-07-02 2024-02-20 Janssen Sciences Ireland Uc Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação
CN108348510B (zh) 2015-09-17 2022-01-04 圣母大学 针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物
MX2018015657A (es) * 2016-06-16 2019-03-14 Janssen Sciences Ireland Unlimited Co Compuestos heterociclico como antibacterianos.
BR112018076126A2 (pt) 2016-06-16 2019-03-26 Janssen Sciences Ireland Unlimited Company compostos heterocíclicos como antibacterianos
CN106588916A (zh) * 2016-11-21 2017-04-26 浙江司太立制药股份有限公司 N‑(苯氧乙基)咪唑并[1,2‑a]吡啶‑3‑酰胺类化合物及其制备方法
BR112019012262A2 (pt) * 2016-12-16 2019-12-03 Bayer Ag imidazopiridinas mesoiônicas para uso como inseticidas
EP4417262A3 (fr) 2017-03-01 2024-11-27 Janssen Sciences Ireland Unlimited Company Polythérapie
CN108159049B (zh) * 2018-02-01 2021-01-05 中国科学院广州生物医药与健康研究院 一种吡啶类化合物的新用途
US20210009583A1 (en) * 2018-03-12 2021-01-14 University Of Notre Dame Du Lac Deuterated imidazopyridines
CN110759913B (zh) * 2018-07-26 2022-01-28 南开大学 吲哚酰腙衍生物及其制备方法和在防治植物病毒、杀菌、杀虫方面的应用
CN113480541B (zh) * 2019-03-07 2022-09-02 湖南化工研究院有限公司 咪唑并吡啶化合物及其中间体的制备方法
AR118612A1 (es) * 2019-04-08 2021-10-20 Pi Industries Ltd Compuestos de oxadiazol para controlar o prevenir hongos fitopatogénicos
TWI861208B (zh) 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
CA3174311A1 (fr) 2020-06-02 2021-12-09 Chuanwu ZHAO Compose 3,4-dihydroisoquinoleine et son utilisation
CN115073454B (zh) * 2022-08-09 2024-03-08 贵州大学 一种咪唑并吡啶-2-噁唑啉类化合物及其制备方法和应用
WO2024161423A1 (fr) * 2023-02-02 2024-08-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Petites molécules pour le traitement de maladies mycobactériennes

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525602A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
PT77844B (en) * 1982-12-27 1986-05-08 Lilly Co Eli Process for preparing substituted imidazopyrimidines -pyrazines and -triazines
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
DE4010797A1 (de) 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DE4023215A1 (de) 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
JPH0539205A (ja) 1990-12-21 1993-02-19 Takeda Chem Ind Ltd 農園芸用混合組成物
JP3026845B2 (ja) 1991-02-20 2000-03-27 日清製粉株式会社 ピペリジン誘導体
US5464843A (en) 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
US5721273A (en) * 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
WO1995028389A1 (fr) 1994-04-15 1995-10-26 Yamanouchi Pharmaceutical Co., Ltd. Compose spiro et composition medicinale issue de ce compose
WO1996002542A1 (fr) 1994-07-15 1996-02-01 Takeda Chemical Industries, Ltd. Composes tricycliques, leur production et utilisation
US6323227B1 (en) 1996-01-02 2001-11-27 Aventis Pharmaceuticals Products Inc. Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
US6080767A (en) 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
JPH09249666A (ja) 1996-01-12 1997-09-22 Takeda Chem Ind Ltd 三環性化合物の製造法およびその中間体
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
AUPP278498A0 (en) * 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
US6288234B1 (en) 1998-06-08 2001-09-11 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
GB2351081A (en) 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
CZ2002959A3 (cs) 1999-09-17 2002-07-17 Millennium Pharmaceuticals, Inc. Inhibitory faktoru Xa
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
CN1173975C (zh) 2000-04-27 2004-11-03 山之内制药株式会社 咪唑并吡啶衍生物
WO2002002557A2 (fr) * 2000-06-30 2002-01-10 Neurogen Corporation Derives imidazo[1,2-a]pyridine 2-substitues
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
DE10247269A1 (de) * 2002-10-10 2004-04-22 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yl-methylamine
WO2004100868A2 (fr) 2003-04-23 2004-11-25 Abbott Laboratories Procede servant a traiter le rejet d'un transplant
AU2004309166B2 (en) 2003-12-23 2008-02-21 Pfizer Inc. Novel quinoline derivatives
JPWO2005108399A1 (ja) * 2004-05-10 2008-03-21 萬有製薬株式会社 イミダゾピリジン化合物
US20060084806A1 (en) * 2004-07-21 2006-04-20 Ramasubramanian Sridharan Processes for the preparation of imidazo[1,2-a] pyridine derivatives
EP1778685B1 (fr) * 2004-08-02 2008-03-26 Schwarz Pharma Ag Carboxamides d'indolizine et leurs aza- et diaza-derives
RU2007121864A (ru) * 2004-11-11 2008-12-20 Феррер Интернасионал ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ), КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРОВ GABAA, ИЛИ α1-GABAA, ИЛИ α2-GABAA (ВАРИАНТЫ)
MY140868A (en) * 2004-12-24 2010-01-29 Astrazeneca Ab Amide derivatives
WO2007015866A2 (fr) 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibiteurs de la p38 kinase et procédés de traitement d’affections inflammatoires
AU2007254361A1 (en) 2006-05-18 2007-11-29 Merck Sharp & Dohme Corp. Substituted esters as Cannabinoid-1 receptor modulators
FR2903178B1 (fr) 2006-07-03 2008-10-03 Rech S De L Ecole Nationale Su Procede et dispositif de nettoyage des surfaces de ruissellement d'eau dans un echangeur thermique air/eau
JP2010504957A (ja) * 2006-09-29 2010-02-18 アクテリオン ファーマシューティカルズ リミテッド 3−アザ−ビシクロ[3.1.0]ヘキサン誘導体
EP2068869A4 (fr) 2006-10-06 2011-05-25 Abbott Lab Nouveaux imidazothiazoles et imidazoxazoles
CN101631786A (zh) 2006-12-20 2010-01-20 先灵公司 新颖的jnk抑制剂
JP2010520293A (ja) 2007-03-07 2010-06-10 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド 複素環式部分を含有するメタロプロテアーゼ阻害剤
EP1980251A1 (fr) 2007-04-13 2008-10-15 Glaxo Group Limited Derivées de pyrrolo[3,2,1-ij]quinoline-4-one pour traiter la tuberculose
TW200901969A (en) 2007-06-06 2009-01-16 Smithkline Beecham Corp Chemical compounds
WO2009015208A1 (fr) * 2007-07-23 2009-01-29 Replidyne, Inc. Composés urée hétérocycliques substitués par amide et sulfonamide antibactériens
WO2009086303A2 (fr) 2007-12-21 2009-07-09 University Of Rochester Procédé permettant de modifier la durée de vie d'organismes eucaryotes
CA2724842A1 (fr) * 2008-05-19 2009-11-26 Sunovion Pharmaceuticals Inc. Composes imidazo[1,2-a]pyridines
WO2009148961A2 (fr) 2008-05-29 2009-12-10 Wisconsin Alumni Research Foundation Médicaments pour prévenir une infection par papillomavirus
JP5536773B2 (ja) 2008-08-14 2014-07-02 ベータ・ファーマ・カナダ・インコーポレイテッド Ep4受容体アンタゴニストとしてのヘテロ環式アミド誘導体
US8198449B2 (en) * 2008-09-11 2012-06-12 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
US8293909B2 (en) 2008-09-11 2012-10-23 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis C
EP2376490B1 (fr) * 2008-12-04 2013-01-23 Proximagen Limited Composés imidazopyridines
WO2011050245A1 (fr) 2009-10-23 2011-04-28 Yangbo Feng Hétéroaryles bicycliques formant inhibiteurs de la kinase
EP2496578A4 (fr) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac Composés d'imidazo[1,2-a]pyridine, leur synthèse et procédés pour les utiliser
CA2793086C (fr) * 2010-03-18 2018-08-21 Institut Pasteur Korea Composes d'imidazo[1,2-a]pyridine substitue et leur utilisation pour le traitement d'infections bacteriennes

Also Published As

Publication number Publication date
CN110483499A (zh) 2019-11-22
US20160318925A1 (en) 2016-11-03
EP2496578A2 (fr) 2012-09-12
US20180354944A1 (en) 2018-12-13
IL219564A (en) 2017-01-31
RU2012122653A (ru) 2013-12-10
EP2496578A4 (fr) 2013-08-21
EP3257854A1 (fr) 2017-12-20
CN102762556A (zh) 2012-10-31
BR112012010752B1 (pt) 2021-07-20
WO2011057145A2 (fr) 2011-05-12
US9309238B2 (en) 2016-04-12
CN102762556B (zh) 2017-04-26
BR112012010752A2 (pt) 2020-09-15
US9908876B2 (en) 2018-03-06
IL219564A0 (en) 2012-06-28
CN106866667B (zh) 2019-11-15
RU2608611C2 (ru) 2017-01-23
ZA201204028B (en) 2013-11-27
HK1248676A1 (en) 2018-10-19
CN106866667A (zh) 2017-06-20
WO2011057145A3 (fr) 2011-09-09
US20120220457A1 (en) 2012-08-30
US10913737B2 (en) 2021-02-09

Similar Documents

Publication Publication Date Title
IN2012DN04917A (fr)
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
MX340490B (es) Derivados de pirazolo [1, 5a] pirimidina y de tieno [3, 2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
WO2012007345A3 (fr) Imidazo[1,2-a]pyrimidines et -pyridines substitués
TNSN07323A1 (en) Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors
IL187586A0 (en) Method for producing dihydroquinazolines
TW200736260A (en) Inhibitors of Akt activity
WO2008121687A3 (fr) Composés imidazo[1,2-a]pyridine en tant qu'inhibiteurs de la tyrosine kinase récepteur
WO2006136357A3 (fr) Modifications cristallines de la pyraclostrobine
WO2011101069A3 (fr) Hétarylaminonaphtyridines
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
EP2142543B8 (fr) Composés pyrido [2, 3-d]pyrimidin-7-one utilisés en tant qu'inhibiteurs de pi3k-alpha pour le traitement du cancer
EP2142544B8 (fr) Composés pyrido [2, 3-d]pyrimidin-7-one utilisés en tant qu'inhibiteurs de pi3k-alpha pour le traitement du cancer
AP2492A (en) Novel compositions of fungal inocula, method for the preparation thereof and use thereof for improving the growth of cultures
MX2011008452A (es) Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata.
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
WO2009114703A3 (fr) Thérapie combinée pour le traitement d'un cancer
PH12014500317A1 (en) Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
WO2009127718A3 (fr) Nouveaux microbiocides
WO2008021346A3 (fr) Palipéridone pure et ses procédés d'obtention
TW200700064A (en) Novel compounds
MX2010002477A (es) Perharidinas como inhibidores de cdk.
TW200716110A (en) Inhibitors of AKT activity
WO2008089005A3 (fr) Inhibiteurs de rénine
NZ591837A (en) Amino acid derivative